Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antigens"" wg kryterium: Temat


Tytuł:
Contribution of HLA class I (A, B, C) and HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes in exploring ethnic origin of central Tunisians.
Autorzy:
Ben Bnina A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Yessine A; Biochemistry Laboratory, Béchir Hamza Children's Hospital, Bab Saadoun Square, 1007, Tunis, Tunisia. .; Department of Educational Sciences, University of Jendouba, Higher Institute of Applied Studies in Humanity Le Kef, Kef, Tunisia. .
El Bahri Y; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Chouchene S; Hematology Laboratory, Fatouma Bourguiba Teaching Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Ben Lazrek N; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mimouna M; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mlika Z; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Messoudi A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Zellama D; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Sahtout W; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Bouatay A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 29; Vol. 17 (1), pp. 65. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Genetic*
HLA-C Antigens*/genetics
North African People*
Humans ; Haplotypes ; HLA-DRB1 Chains/genetics ; Alleles ; Gene Frequency ; HLA-B Antigens/genetics ; HLA-A Antigens/genetics
Czasopismo naukowe
Tytuł:
Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function.
Autorzy:
Liu Y; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Ren S; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Ma L; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Lin X; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Lu J; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Cao Z; Third Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Zheng S; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Hu Z; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Xu X; Department of Core Facility Center, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China.
Chen X; First Department of Liver Disease Center, Beijing Youan Hospital, Capital Medical University, No.8, Xi Tou Tiao, Youanmen wai, Beijing, 100069, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2024 Mar 30; Vol. 21 (1), pp. 77. Date of Electronic Publication: 2024 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*
Hepatitis B, Chronic*/drug therapy
Humans ; Interferon-alpha/therapeutic use ; Seroconversion ; Hepatitis B Vaccines/therapeutic use ; Cytokines ; Hepatitis B Antibodies ; Vaccination ; Immunity ; Hepatitis B e Antigens ; Antiviral Agents/therapeutic use ; Polyethylene Glycols/therapeutic use
Czasopismo naukowe
Tytuł:
Renal graft function in transplanted patients correlates with CD45RC T cell phenotypic signature.
Autorzy:
Bézie S; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Sérazin C; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Autrusseau E; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Vimond N; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Giral M; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.; Department of Nephrology, CHU Nantes, Nantes Université, ITUN, Nantes, France.
Anegon I; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Guillonneau C; Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, F-44000, Nantes, France.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0300032. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
CD8-Positive T-Lymphocytes*
HLA-DR Antigens*
Humans ; Reproducibility of Results ; Leukocyte Common Antigens/metabolism ; Graft Rejection ; Protein Tyrosine Phosphatases ; Biomarkers
Czasopismo naukowe
Tytuł:
Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation.
Autorzy:
Kulicke CA; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Swarbrick GM; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Ladd NA; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, 60637, USA.
Cansler M; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Null M; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Worley A; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Lemon C; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Ahmed T; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Bennett J; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Lust TN; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Heisler CM; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.
Huber ME; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Krawic JR; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Ankley LM; Department of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, 48824, USA.
McBride SK; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Tafesse FG; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.
Olive AJ; Department of Microbiology and Molecular Genetics, College of Osteopathic Medicine, Michigan State University, East Lansing, MI, 48824, USA.
Hildebrand WH; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Lewinsohn DA; Division of Infectious Diseases, Department of Pediatrics, Oregon Health & Science University, Portland, OR, 97239, USA.
Adams EJ; Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, 60637, USA.
Lewinsohn DM; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA.; VA Portland Health Care System, Portland, OR, 97239, USA.
Harriff MJ; Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, OR, 97239, USA. .; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. .; VA Portland Health Care System, Portland, OR, 97239, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2024 Feb 24; Vol. 7 (1), pp. 228. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class I*/metabolism
Lymphocyte Activation*
Ribitol/*analogs & derivatives
Uracil/*analogs & derivatives
Ligands ; Antigen Presentation ; Antigens/metabolism
Czasopismo naukowe
Tytuł:
Characteristics and clinical treatment outcomes of chronic hepatitis B children with coexistence of hepatitis B surface antigen (HBsAg) and antibodies to HBsAg.
Autorzy:
Gu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Li S; Liver Disease Center, Hunan Children's Hospital, Changsha, 410000, China.
Yao Z; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Lai X; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Yang M; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Xu Y; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China.
Peng S; Department of Maternal and Child Health, Xiangya School of Public Health, Central South University, No. 172 Tongzipo Road, Yuelu District, Changsha, Hunan, 410078, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2024 Feb 20; Vol. 22 (1), pp. 77. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B Surface Antigens*/therapeutic use
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Child ; Humans ; Child, Preschool ; Hepatitis B e Antigens/therapeutic use ; Retrospective Studies ; Hepatitis B virus ; Treatment Outcome ; Hepatitis B Antibodies/therapeutic use ; Antiviral Agents/therapeutic use
Czasopismo naukowe
Tytuł:
The Role of the CD28 Family Receptors in T-Cell Immunomodulation.
Autorzy:
Ciesielska-Figlon K; Department of Physiopathology, Medical University of Gdansk, 80-211 Gdansk, Poland.
Lisowska KA; Department of Physiopathology, Medical University of Gdansk, 80-211 Gdansk, Poland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 20; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
CD28 Antigens*
T-Lymphocytes*
CTLA-4 Antigen ; Programmed Cell Death 1 Receptor ; Antigens, CD ; Immunity ; Immunomodulation ; Antigens, Differentiation, T-Lymphocyte ; Lymphocyte Activation
Czasopismo naukowe
Tytuł:
HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis.
Autorzy:
Held M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Stingl Jankovic K; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Sestan M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Sapina M; Department of Pediatrics, University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, 31000 Osijek, Croatia.
Kifer N; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Srsen S; Department of Pediatrics, University of Split School of Medicine, University Hospital Centre Split, 21000 Split, Croatia.
Frkovic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Gagro A; Children's Hospital Zagreb, Medical Faculty Osijek, Josip Juraj Strossmayer University of Osijek, 10000 Zagreb, Croatia.
Grubic Z; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Jelusic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
HLA Antigens*/genetics
IgA Vasculitis*/genetics
Genetic Predisposition to Disease*
Child ; Humans ; HLA-A Antigens ; HLA-B Antigens ; HLA-DRB1 Chains/genetics
Czasopismo naukowe
Tytuł:
Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy.
Autorzy:
Liu R; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Jiang T; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Lu Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhang L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Shen G; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Wu S; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Chang M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hao H; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hu L; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Gao Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Xu M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Chen X; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yi W; Department of Obstetrics and gynecology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li M; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Xie Y; Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Virulence [Virulence] 2023 Dec; Vol. 14 (1), pp. 2186335.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B Core Antigens*/therapeutic use
Hepatitis B, Chronic*/drug therapy
Humans ; Female ; Pregnancy ; Hepatitis B virus ; Hepatitis B Surface Antigens/therapeutic use ; Pregnant Women ; Hepatitis B e Antigens/therapeutic use ; Antiviral Agents/therapeutic use ; DNA, Viral/analysis ; Biomarkers
Czasopismo naukowe
Tytuł:
Neural network models for sequence-based TCR and HLA association prediction.
Autorzy:
Liu S; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
Bradley P; Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Institute for Protein Design. University of Washington, Seattle, Washington, United States of America.
Sun W; Biostatistics Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.; Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Pokaż więcej
Źródło:
PLoS computational biology [PLoS Comput Biol] 2023 Nov 20; Vol. 19 (11), pp. e1011664. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
HLA Antigens*/genetics
HLA Antigens*/chemistry
Histocompatibility Antigens Class I*
Humans ; Receptors, Antigen, T-Cell/genetics ; Histocompatibility Antigens Class II ; Neural Networks, Computer
Czasopismo naukowe
Tytuł:
Molecular Signature of Monocytes Shaped by the Shigella sonnei 1790-Generalized Modules for Membrane Antigens Vaccine.
Autorzy:
Tondi S; Preclinical Research & Development, GSK, 53100 Siena, Italy.; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Siena E; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Essaghir A; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Bozzetti B; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Bechtold V; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Scaillet A; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
Clemente B; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Marrocco M; Preclinical Research & Development, GSK, 53100 Siena, Italy.; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Sammicheli C; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Tavarini S; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Micoli F; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
Oldrini D; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
Pezzicoli A; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Di Fede M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Brazzoli M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Ulivieri C; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Schiavetti F; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 17; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Vaccines*
Blood Group Antigens*
Gastroenteritis*
Methylmethacrylates*
Humans ; Monocytes ; Shigella sonnei/genetics ; Antigens, Bacterial/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies